CX3CL1 and ovarian carcinoma: Thus, despite activating the adaptive immune system against ovarian cancer growth, most likely through T-cell recruitment, CX3CL1 overexpression promotes intraperitoneal tumour spread and shortens survival, very well reflecting the adverse prognostic impact in human HGSOC as shown before.